Seres Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Seres Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $213k | 14k | 14.88 |